Commodore Capital LP - 10%+ Owner at Enliven Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Company
Role
10%+ Owner
Issuer Symbol
ELVN on Nasdaq
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Commodore Capital LP since 05 Jan 2025

Holdings reported by Commodore Capital LP for Enliven Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock, par value $0.001 per share 1,448,640 $21,925,166 $15.14 23 Feb 2023 By Commodore Capital Master LP

Transactions reported by Commodore Capital LP for Enliven Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.